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Local mRNA translation mediates the adaptive re-
sponses of axons to extrinsic signals, but direct evi-
dence that it occurs in mammalian CNS axons in vivo
is scant. We developed an axon-TRAP-RiboTag
approach in mouse that allows deep-sequencing
analysis of ribosome-bound mRNAs in the retinal
ganglion cell axons of the developing and adult reti-
notectal projection in vivo. The embryonic-to-post-
natal axonal translatome comprises an evolving
subset of enriched genes with axon-specific roles,
suggesting distinct steps in axon wiring, such as
elongation, pruning, and synaptogenesis. Adult
axons, remarkably, have a complex translatome
with strong links to axon survival, neurotransmission,
and neurodegenerative disease. Translationally co-
regulated mRNA subsets share common upstream
regulators, and sequence elements generated by
alternative splicing promote axonal mRNA transla-
tion. Our results indicate that intricate regulation of
compartment-specific mRNA translation in mamma-
lian CNS axons supports the formation and mainte-
nance of neural circuits in vivo.
INTRODUCTION
RNA localization and local translation are evolutionarily
conserved mechanisms employed by cells to control the precise
subcellular positioning of nascent proteins. Neurons are highly
compartmentalized cells with functionally distinct cytoplasmic/
membrane domains (dendrites, axons, and somas), and
emerging evidence indicates that localized mRNA translation
supports this subcellular differentiation (Holt and Schuman,
2013; Martin and Ephrussi, 2009). Recent in vitro studies re-
vealed an unexpectedly large population of mRNAs in axons,
and inhibiting the translation of just one or two of them can cause
specific defects in fundamental axonal behaviors, such as neu-
rotrophin-induced outgrowth, branching, cue-induced chemo-Cell 166, 181–192, J
This is an open access article undtropic responses, and injury-induced regeneration (references
in Jung et al., 2012). In vitro studies have also provided evidence
that extrinsic signals, such as guidance cues and growth factors,
selectively induce rapid axonal synthesis of distinct protein sub-
sets (references in Jung et al., 2012). A rational interpretation of
these results is that specific subsets of mRNAs are coordinately
translated when required whereas most axonally localized
mRNAs remain translationally repressed. Thus, to understand
the function of axonal mRNA translation, it is important to carry
out a comprehensive and unbiased global analysis of themRNAs
that are specifically translated in the axonal compartment in vivo.
The axons of retinal ganglion cells (RGCs) terminate in the su-
perior colliculus (SC) of the midbrain. A point-to-point topo-
graphic projection of RGC axons to the SC allows the brain to
reconstruct a map of the outside world. In mouse, the formation
of this retinotopicmap in the SC can be divided into three distinct
phases (Feldheim and O’Leary, 2010). First, embryonic RGC
axons enter the SC and initially extend beyond their topograph-
ically correct ‘‘termination zones (TZs)’’ without branching or
synapsing (‘‘elongation’’ period). Second, interstitial branches
arise from the primary axon shafts of RGCs in their appropriate
TZs and begin to form synapses (‘‘branching/synaptogenesis’’
period). Third, in the first 2 postnatal weeks, correctly wired
axon branches are strengthened and excess inappropriate
branches are pruned (‘‘pruning’’ period), resulting in the mature
topographic map in adulthood (Figure 1A; Godement et al.,
1984). Intriguingly, evidence suggests that local mRNA transla-
tion in the RGC axons may regulate subtle aspects of the forma-
tion of the retinotectal projection in vivo (Brunet et al., 2005). It is
not known, however, which mRNAs are axonally translated and
which specific aspects of visual circuit assembly they affect.
To address this issue, we developed axon-TRAP (translating
ribosome affinity purification) in mouse, a method that allows
specific isolation of ribosome-bound mRNAs in the distal
compartment of RGC axons in vivo. Analysis of these axon-spe-
cific translatomes at multiple ages reveals that axonal translation
may play two major roles: regulation of protein and energy
homeostasis, which is supported bymRNAs constitutively trans-
lated regardless of developmental stage, and regulation of
stage-specific events, such as axon elongation, branching,
pruning, synapse formation, and synaptic transmission, whichune 30, 2016 ª 2016 The Author(s). Published by Elsevier Inc. 181
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Retinal RiboTag Labels RGC
Axonal Ribosomes In Vivo
(A) Development of retinal ganglion cell (RGC)
axons in the superior colliculus (SC).
(B) Strategy of axon-TRAP.
(C) PCR detection of Cre transgene (upper) and
Rpl22 allele (lower).
(D) PCR of genomic DNA from the retina and
the SC that distinguish recombined and un-
recombined RiboTag alleles.
(E) HA fluorescence immunohistochemistry.
(F–L) HA immuno-gold electron microscopy (EM).
HA-tagged ribosomes localize to retinal cell bodies
(F) andRGCaxons (Ax) in theopticnervehead (ONH)
(H), optic nerve (ON) (I), and RGC axon terminals in
theSC(JandK).Twoormoreadjacentgoldparticles
(purple arrows) were regarded as specific signals.
Scatteredsingle immuno-goldparticlesmaybenon-
specific (yellow asterisks). Ultrastructure of poly-
somes is visible in the cell bodies in the retina and
the SC (white arrows), but these co-localize with
immuno-gold only in the retina (F). Cre-negative
littermate shows no specific labeling (G).
E, embryonic day; Nuc, nucleus; P, postnatal
day. The scale bars represent 500 mm (E) and
500 nm (F–L).
See also Figure S1.is supported by mRNAs whose translation is developmentally
regulated. We also found that axonal mRNA translation con-
tinues in adulthood, when regulators of neurotransmission and
axon survival are locally translated. Bioinformatic analysis of
key translational regulators, such as mammalian target of rapa-
mycin complex 1 (mTORC1), fragile X mental retardation protein
(FMRP), and adenomatous polyposis coli (APC), reveals that
their target mRNAs are translationally co-regulated in a stage-
specific manner. In addition, axonally translated mRNAs show
extensive isoform diversity, yet only one single isoform is usually182 Cell 166, 181–192, June 30, 2016translated at any given time and these
axonally translated isoforms share com-
mon regulatory sequence motifs that
promote axonal mRNA translation.
Collectively, the results provide direct
evidence for the occurrence of develop-
mental stage-specific, compartmental-
ized mRNA translation in developing
and mature CNS axons and provide a
deeper understanding of the molecular
machinery involved in CNS wiring and
maintenance.
RESULTS
Retinal RiboTag Labels RGC Axonal
Ribosomes In Vivo
In order to isolate mRNAs translated in
RGC axon terminals in the SC in vivo,
we used the RiboTag knockin mouse
line (Sanz et al., 2009), in which Cre-medi-ated recombination switches the RiboTag allele, which encodes
the 60S subunit protein ribosomal protein L22 (RPL22), to the
hemagglutinin (HA)-tagged Rpl22 allele (Rpl22-HA). We crossed
this mouse with a Pax6-alpha-Cre mouse (Marquardt et al.,
2001), which transiently expresses Cre in the neural progenitors
in the peripheral retinal primordium, permanently labeling RGCs
(Figure 1B; green area in the eye). We confirmed that no resident
cells in the SC express Cre by two independent approaches, his-
tological and molecular biological assays (Figures 1C, 1D, and
S1; see Supplemental Experimental Procedures). Therefore,
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Figure 2. Unbiased Identification of the
Axonal Translatome
(A) HA-labeled ribosomes were TRAPed by two in-
dependent antibodies against HA, and then co-
immunoprecipitated ribosomal proteins from 60S
(i.e., rpL24) and 40S (i.e., rpS3a) were visualized by
western blot. IgG LC, immunoglobulin G light chain.
(B) Double-strand cDNAs were made from TRAPed
RNAs.
(C) Read counts of adult SC samples with or without
ribosome run-off. Left panel is a scatter plot of
log2 (read count+1), and right panel represents the
percentage of genes whose read counts were
decreased by run-off.
(D) A scatterplot of log2 (FPKM) between Cre-pos-
itive/-negative (x axis) and Cre-negative axons
(y axis) at stage P0.5.
(E) Change in numbers of DEGs in the retina and
axon. For axon, dark pink indicates DEGs at the
corresponding stages. Light pink indicates genes
that are DEGs only at that stage. Combined value of
orange and peach (union of DEGs) indicates the
size of axonal translatome.
(F) Somal versus axonal translatomes.
(G) Four different axonal translatomes.
See also Figure S2.the immunopurification of ribosome-mRNA complexes from the
dissected SC allows us to profile local translation in axon termi-
nals of RGCs in vivo (axon-TRAP; Figure 1B).
We sought to visualize the labeled ribosomes using an HA anti-
body.HA immunoreactivitywasobserved in thedistal neural retina
(Figures 1E and S1) and the optic nerve head (ONH) (Figure 1E,
white box), the soma-free region where RGC axons collect to
exit the eye, indicating that the RGC axons do contain HA-tagged
ribosomes. To visualize the tagged ribosomes with higher resolu-
tion, we employed immuno-electron microscopy (EM). Immuno-
goldparticles specifically labeleda subpopulation of ultrastructur-
ally identifiable ribosomes (Figure 1F) in the distal neural retina in aCre-dependent manner (Figure 1G). We
successfully detected HA-tagged ribo-
somes in the axon shaft in the ONH and
the optic nerve (ON) (Figures 1H and 1I)
andpresynaptic terminals in theSC (Figures
1J–1L) at all stages, indicating that HA-
labeled endogenous ribosomes are trans-
ported to the axon, even in the adult.
Together, our histological, molecular bio-
logical, andultrastructural analyses indicate
that Retinal RiboTag faithfully labels retinal
axonal ribosomes in the SC.
An Unbiased Identification of the
Axonal Translatome
Because the mRNA bound to the labeled
axonal ribosomes of RGCs represents
only a small fraction of the mRNA in the
SC, a major caveat of axon-TRAP is non-
specific binding of mRNAs derived fromthe SC cells to immunoglobulins, Protein G, and magnetic
beads. To reduce this background noise, we first optimized the
immunopurification protocol before performing axon-TRAP.
We estimated that approximately 40% of HA-tagged translating
ribosomes could be purifiedwith this optimized protocol (Figures
2A, S2A, and S2B; see Supplemental Experimental Procedures).
Successful isolation of axonal ribosomes was confirmed by sil-
ver staining (Figure S2B) followed bymass spectrometry (unpub-
lished observation), although RPL22-HA pulled down from the
SC was below the level of detection by western blot. To assess
the levels of background noise, we compared the levels of
cDNAs amplified from TRAPed mRNAs (Figure S2C) betweenCell 166, 181–192, June 30, 2016 183
Figure 3. Comparison between the Axonal and Retinal
Translatomes
(A) Normalized mRNA levels (log2(FPKM)) between the axonal (y axis) and
retinal (x axis) translatome at stage P0.5. Axon- and retina-enriched population
were defined when FPKMaxon/FPKMretina > 100 and <0.1, respectively.
(B) GO terms in the cellular component category. More detailed lists are in
Figure S3B (gray, not detected).
(C) ClueGO analysis. The left axis indicates the parental GO terms. The per-
centage of daughter GO terms associated with somal and axonal translatome
is presented.
See also Figure S3.the Cre-positive and -negative littermates. Although axon-TRAP
was clearly dependent on Cre and therefore specific, additional
amplification led to an increased background (Figure 2B). We
took advantage of this background ‘‘noise,’’ reasoning that the
Cre-negative samples would control for all the potential causes
of false-positive signals that any technical modification could
not completely eliminate.
In addition to avoiding any noise in the signal, we also wanted
to assure ourselves that the signal came from mRNAs that were
actively being translated, because 80S ribosomes can be stalled
during translation by translational repressors, such as FMRP
(Darnell et al., 2011). In vitro ribosome run-off (see Supplemental
Experimental Procedures) decreased the amount of TRAPed
mRNAs to the degree that it could not be distinguished from
the Cre-negative control (Figure S2D), indicating that themajority
of TRAPed mRNA comes from actively translating ribosomes.
RNA sequencing analysis showed that we could detect 85% of
TRAPed mRNAs isolated from adult axons as being actively
translated (Figures 2C and S2E). We use the term ‘‘translatome’’
for ribosome-bound mRNAs in this study, but it should be noted
that approximately 15% of these may represent translation-
stalled mRNAs.184 Cell 166, 181–192, June 30, 2016Axon-TRAP Identifies Changing Population of
Ribosome-Bound mRNAs in Developing and Mature
Axons In Vivo
We used axon-TRAP on SCs dissected out at three specific
stages during retinotectal development and in the adult: embry-
onic day 17.5 (E17.5) (elongating); postnatal day 0.5 (P0.5)
(branching); P7.5 (pruning); and adult (mature; Figure 1A). To
compare the axonal translatome with the somal translatome,
we also analyzed the ribosome-bound mRNAs in dissected
Cre-positive retina, which contains the cell bodies of RGCs.
When we plotted the normalized read count (fragments per
kilobase of transcript per million mapped reads [FPKM]) of
each mRNA TRAPed from Cre-positive over Cre-negative
SC samples, Cre-dependent signals of mRNAs were immedi-
ately visible (Figure 2D, left panel, black dots). This was in
contrast with the plot with two biological replicates of Cre-
negative SC samples, which showed a clear correlation (Fig-
ure 2D, left panel, blue dots). To select Cre-dependent mRNAs
in an unbiased way, we performed ‘‘differential expression anal-
ysis’’ on biological replicates of Cre-positive and -negative
samples using NOIseq, which is well suited for quantitative
comparisons for independently performed RNA-seq samples
(Tarazona et al., 2011; Figures 2D and S2F; see Supplemental
Experimental Procedures). We defined these genes as ‘‘differen-
tially expressed genes (DEGs)’’ (Figures 2D and S2F, right panel,
red dots; Table S1) and used these for most of the downstream
analyses.
The total number of axonally translated mRNAs was higher in
early stages, peaking at P0.5, and decreased postnatally,
whereas mRNAs that are translated within the retinal somas
showed little change over the periods examined (Figure 2E),
consistent with the amounts of axon-TRAPed cDNAs (Fig-
ure S2A). Although previous studies demonstrated that proteins
are synthesized in developing axons, it has been controversial
whether mature CNS axon terminals also have the ability to syn-
thesize proteins at all, partly because of early studies detecting
few or no ribosomes in mature axons (references in Piper and
Holt, 2004). However, the presence of DEGs, approximately
85% of which were confirmed as being translated (Figures 2C
and S2E) and ribosomes (Figures 1I and 1L) in adult axons indi-
cates that axonal mRNA translation persists in adult CNS axons.
The axonal translatome of RGCs is largely an evolving subset of
the significantly larger somal translatome (Figure 2F), confirming
that axon-TRAPed mRNAs originate from RGC neurons. Unlike
the somal translatome (Figure S3A), however, the axonal transla-
tome showed extensive developmental regulation (see detailed
analysis below) with only 694 out of 2,576 (27%) mRNAs trans-
lated at all stages (Figures 2G and S3A), indicating that the
axonal translatome is not due to the simple passive diffusion of
translated mRNAs from the soma.
Axon-TRAPed mRNAs Encode Axon-Specific Proteome
To discover which classes of mRNAs are preferentially trans-
lated in the axon, we performed a gene ontology (GO) enrich-
ment/depletion analysis for genes whose translation level is
significantly higher (>100-fold difference) in the axon than in
the retina (Figure 3A; ‘‘axon-enriched mRNAs’’). Reassuringly,
analysis with the cellular component category showed that
AB
Figure 4. Developmental Changes of Trans-
lated Genes in RGC Axons
(A) Enriched GO (biological process) terms and
Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathways for axonally translated genes
(grey, not detected), sorted by significance for
each stage (Fisher’s exact test). The enrichment
was analyzed by topGO (Table S3). Statistically
significant cells are marked by black squares.
(B) Normalized levels of axonal translation for
selected genes (gray, not detected).
See also Figure S4.axon-enriched mRNAs generally encode proteins that are
already known to function in axons, growth cones, and synapses
(Figures 3B and S3B). In contrast, mRNAs encoding nuclear
proteins (e.g., modifier of chromatin structures) are depleted
from axonal translatome. GO terms selectively enriched in the
axonal translatome included those involved in vesicle-mediated
transport and calcium-mediated signaling (Figure S3C), sug-
gesting that these processes, which play key roles in the distal
axon, may be regulated by local mRNA translation.To explicitly compare axonal and somal
translatomes, we used ClueGO software,
which reports how many genes in each
cluster are assigned with specific GO
terms. We compared 2,576 axonally
translated mRNAs (‘‘axonal translatome’’)
with the same number of mRNAs that are
most abundant in the somal translatome
but absent in the axonal translatome
(‘‘retina-only’’ translatome). We found
that synapse- and axon-related GO terms
were generally associated with the axonal
translatome, whereas the retina-only
translatome was enriched with basal
body and nuclear GO terms (Figure 3C).
These results indicate the presence
of mechanisms for selecting specific
mRNAs for axonal translation.
Axonal Translatome Changes
from Axon Elongation to
Neurotransmission during
Development
To correlate the local translation with the
stage-specific events in axon develop-
ment, we performed a GO-based analysis
for genes that are translated in axons at
each developmental stage using 455
neuron-related GO terms (Table S2). The
translatome in younger axons (E17.5 and
P0.5) was highly enriched with axon-
development-related GO terms, including
‘‘neuron projection morphogenesis,’’
whereas that of older axons (adult) was
enriched with synaptic-transmission-related GO terms, such as ‘‘synaptic transmission’’ (Figures 4A
and S4A; Table S3). The ingenuity pathway analysis (IPA) for ca-
nonical signaling pathways also suggests that synapse function
wasmost highly regulated in adult axons (Figure S4B). This result
suggests that axonal mRNA translation continues in the mature
CNS of mammals in vivo and may regulate presynaptic function.
We found that a number of genes, which are robustly translated
in adult axons, encode glutamate receptors and neurotrophin re-
ceptors (Figures 4B and S4C), some of which are known toCell 166, 181–192, June 30, 2016 185
regulate synaptic transmission in the presynaptic compartment
(Pinheiro and Mulle, 2008). Furthermore, key components of
the trans-SNARE complex, which mediates neurotransmitter
exocytosis, are highly translated in mature axons (Figure 4B),
suggesting that their local translation plays a role in supporting
the core machinery of neurotransmission in presynapses.
Intriguingly, translation of receptors for axon guidance mole-
cules peaks around birth (P0.5) and falls off thereafter (Figures
4B and S4A). Because this is when interstitial branches arise
from axon shafts in a topographically biased manner to connect
with targets (Figure 1A), stage-specific synthesis of these recep-
tors in the RGC axon may help to fine-tune topographically
biased branching. We also noted that the GO terms ‘‘neuron re-
modeling’’ and ‘‘collateral sprouting’’ were amongmost enriched
in the pruning stage (P7.5). Genes that function in synapse as-
sembly, which include neurexins and presynaptic cell adhesion
molecules, were translated in all axons (Figures 4B and S4A).
The Axonal Translatome Changes from Degenerative to
Survival Modes at the End of Development
Axon survival is regulated through at least twopathways: bymain-
taining axonal protein/energy homeostasis and by inhibiting a
destruction programmediated by SARM1. Sarm1, which initiates
a soma-independent axon destruction program by counteracting
Nmnat function (Gerdts et al., 2015), is highly translated in devel-
oping, but not in adult, axons (Figures 4B and S4C). The same
pattern of local translation was observed for caspases, whose
local action mediates axon dynamics and developmentally con-
trolled branch destruction (Campbell and Holt, 2003; Campbell
and Okamoto, 2013; Simon et al., 2012). These results suggest
that developing (arborizing) axons synthesize the components of
axon degeneration pathways, perhaps in highly restricted subcel-
lular compartmentswithin the axon, for the selectivewithdrawal of
branches, whereas adult axons shut them off to maintain mature
neural connections for long periods of time.
GO terms related to mitochondrial and homeostatic functions,
such as ‘‘cellular metabolism’’ and ‘‘mitochondrial respiratory
chain,’’ were enriched at all stages, supporting the previous
finding that axonal mRNA translation supports mitochondrial
function and is required for axon survival (Figures 4A and S4A;
Cosker et al., 2016; Hillefors et al., 2007; Yoon et al., 2012).
The survival of a neuron whose axon reaches its correct target
is regulated by retrograde transmission of a survival signal
from the axon terminal, which turns on a transcriptional program
for cell survival (Riccio et al., 1997). Previous studies showed that
axonal synthesis of transcription factors, such as neurotrophin-
induced synthesis of CREB (Cox et al., 2008) and SMAD1/5/8
(Ji and Jaffrey, 2012) and axon-injury-induced synthesis STAT3
(Ben-Yaakov et al., 2012), regulates cell survival during develop-
ment and in adulthood. Indeed, our IPA analysis revealed that
components of these nuclear signaling pathways, including
CREB and STAT3 signaling, are enriched in adult axons (Fig-
ure S4B). Therefore, our results suggest that local translation
promotes survival of mature axons both by supporting mito-
chondrial function and actively generating survival signals.
Pathological axon degeneration in neurodegenerative dis-
eases has been associated with impaired axonal translation
(references in Jung et al., 2012). A KEGG pathway enrichment186 Cell 166, 181–192, June 30, 2016analysis showed a significant over-representation of genes
linked to neurodegenerative diseases, such as Alzheimer’s, Par-
kinson’s, and Huntington’s diseases (Figure 4A). In particular, we
detected robust axonal translation of huntingtin (Htt), Prion pro-
tein (Prnp), microtubule-associated tau (Mapt), and amyloid beta
precursor protein (App), whose aggregates are strongly associ-
ated with neurodegenerative disorders (Figure 4B), suggesting a
possible connection between axonal translation and neurode-
generation involving protein aggregation. Intriguingly, activating
transcription factor 4 (Atf4), whose excessive axonal translation
spreads Alzheimer’s disease pathology across the brain (Baler-
iola et al., 2014), is also axonally translated at all stages tested.
These results support the idea that dysregulated axonal transla-
tion may be an underlying cause of neurodegenerative diseases
(Jung et al., 2012).
Targets ofmTORC1, FMRP, and APCShowTranslational
Co-regulation in a Stage-Specific Manner
We have shown that the axonal translatome is dynamically regu-
lated during development, and this raises the important question
of how axonal translation is controlled by upstream signaling
pathways. To investigate this, we performed IPA upstream regu-
lator analysis, which is based on published data of gene knock-
down or knockout studies where protein products were
measured when translational regulator function was impaired.
mTORC1 activity was predicted to peak in actively wiring axons,
as its target mRNAs showed a steep increase at P0.5 (Fig-
ure S5A), consistent with previous studies demonstrating that
axonal mRNA translation is regulated by mTORC1 (Campbell
and Holt, 2001) and required for axon branching (Spillane
et al., 2013). In contrast, the activity of FMRP was predicted to
peak later at P7.5, because its target mRNAs (whose translation
is repressed) showed a coordinate decrease in translation in
mature axons (Figures 5A, 5B, S5A, and S5B). This result sug-
gests that the translational brake mediated by FMRP is utilized
in maturing CNS axons as in dendrites (Bagni and Greenough,
2005; Darnell and Klann, 2013). Consistent with this result,
known targets of FMRP and mTORC1 in the axonal translatome
showed clearly different translational patterns from the non-
target mRNAs: their translation increased at P0.5 (Figure 5A,
left panel, red and blue; median shifts right) and decreased at
P7.5 (right panel). Another intriguing translational regulator was
APC, which was recently shown to regulate microtubule assem-
bly and axonal growth by local translation (Preitner et al., 2014).
Our analysis indicates that the translation of APC target mRNAs
is highest in the youngest axons (E17.5) and steadily decreases
thereafter (Figures 5A and 5B), consistent with the primary role of
microtubule assembly in axon growth. In contrast, the targets of
TDP-43 and FUS, well-known neuronal RNA-binding proteins
(RBPs), showed a distribution not significantly different from
the total axonal translatome (Figures 5B and S5C), although
the possibility remains that TDP-43 and FUS regulate stage-in-
dependent axonal mRNA translation. A principal-component
analysis (PCA) also showed clear separation of the mTORC1,
FMRP, and APC targets from the rest of the axonal translatome
(Figure S5D). MicroRNAs (miRNAs) make up another class of
translational regulators that function in the axon (Sasaki et al.,
2014). We found that the translation of miR-1 target mRNAs
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Figure 5. Trans-Acting Elements that Regu-
late the Axonal Translatome
(A) Density plots of the change in FPKM values of
axonal translatomes during two consecutive
developmental stages (log2(stage A [FPKM]/stage
B [FPKM]); gray, distribution of all genes; colors,
distribution of target genes) with p values (Kolmo-
gorov-Smirnov test).
(B) Average log2 (FPKM) values of target genes
(mean ± 95% confidence interval).
(C) Representative immunofluorescence images
(left) and their quantification (right; mean ± SEM).
***p < 0.001, Mann-Whitney test. The scale bar
represents 10 mm.
(D) Relationship between transcript abundance of
genes not detected in E17.5 axonal translatome
(read count = 0) and probability of their translation at
later stages (upper left: blue line, mRNA level in
transcriptome; red line, moving averages of per-
centage of genes detected at any of three later
stages over a window size of 100 genes; r, Pearson
correlation coefficient). The upper right and
lower heatmaps show mRNA abundance in the
translatome and enriched regulators/pathways,
respectively.
See also Figure S5.decreases as the axon matures, suggesting that miR-1 abun-
dance and/or activity increases during RGC axonal development
(Figure S5A).
We took an independent approach to investigate the possibil-
ity of developmental-stage-dependent regulation of mTOR and
FMRP signaling in RGC axons. We measured the abundance
of phosphorylated mTOR (p-mTOR) and S6 (p-S6) in cultured
primary mouse RGC axons by quantitative immunofluorescence
(QIF), which positively correlate with mTORC1 activity (Copp
et al., 2009; Laplante and Sabatini, 2012; Figure 5C). We foundthat they increased between E17.5 and
P0.5, supporting our hypothesis that
mTORC1 activity rises in RGC axons dur-
ing this period. In contrast, the level of
FMRP decreased in the same period, in
accordance with our model that the trans-
lational brake is weakened in P0.5 axons
(Figure 5C).
To gain more insight into mRNA-specific
translation in the axon, we compared the
RGC axon transcriptome of E17.5 (Zivraj
et al., 2010) to the axon translatome at
the same stage. We analyzed the genes
that are detected in the transcriptome,
but not in the translatome, because this
group may contain candidates for transla-
tionally repressed (‘‘masked’’) mRNAs.
We found that a significant portion of these
candidates was translated at the three
later stages tested (P0.5, P7.5, or adult)
because their levels in the transcriptome
correlated with the probability for transla-tion at later stages (Figure 5D). This suggests the possibility
that the mRNAs, which are present in high abundance, but not
translated, are being stored for translation in later stages. In
contrast, the genes that are present both in the young transcrip-
tome and translatome did not show this trend (Figure S5E).
Strikingly, mRNAs that are ‘‘unmasked’’ at the same stage
encode various components of specific signaling pathways
(Figure 5D). For example, components of dopamine receptor
signaling, WNT/b-catenin signaling, and the oleic acid biosyn-
thesis pathway were specifically unmasked in P0.5, P7.5, andCell 166, 181–192, June 30, 2016 187
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Figure 6. Alternative Splicing Generates High Isoform Diversity in
Axons
(A) Percentage of genes with alternative events from all axonally translated
genes. Alternative events are classified into five different classes depicted in
the left panel.
(B) Scatter and density plots for the distribution of percentage spliced in (J)
values between the retina (x axis) and the axon (y axis).
(C) Model for biased distribution of J values in the axon. The comparison of
two isoforms suggests that one of two isoforms is predominant in the axon.
(D and E) The sequence reads on Acot7 and Stx3 loci visualized with inte-
grative genomics viewer (IGV). The histograms show the depth of the reads
displayed at each locus. The retinal isoforms are detected only in the retinal
translatome, whereas the axonal isoforms are detected both in the axonal and
retinal translatomes.
See also Figure S6.adult axons, respectively. Additionally, as noted above, mRNAs
that are unmasked at the same stage share common transla-
tional regulators (Figure 5D). Together, these results show that
functionally coherent sets of mRNAs are coordinately translated
in the axon by shared upstream regulators.
Alternative Splicing Generates mRNA Isoform Diversity
in the Axon
Post-transcriptional RNA processing events, including alterna-
tive splicing, are widely used to control gene expression in neu-
rons. To assess whether these regulate local mRNA translation,
we analyzed themRNA isoforms onmapped sequence reads us-
ing MISO software (Katz et al., 2010). Intriguingly, the axonal188 Cell 166, 181–192, June 30, 2016translatome showedmore-extensive diversity of mRNA isoforms
than the somal translatome (Figure 6A). To address the possibil-
ity of isoform-specific axonal translation, we selected 164 alter-
native events that produce two isoforms both in the axonal and
retinal translatomes. Then, we calculated the ‘‘percentage
spliced in’’ (PSI or J) values, which represent the fraction of
the longer isoform (Katz et al., 2010). J retina was uniformly
distributed (0 < J < 1), indicating that there is no clear bias in
translational efficacy (Figures 6B and 6C). However, J axon
was biased to the two extremes (i.e.,J = 0 orJ = 1), indicating
that only one of the two isoforms is selectively translated in the
axon (Figures 6B and 6C). Notable examples are Acot7, an
acyl-coenzyme A (CoA) thioesterase gene required for lipid
biosynthesis and neuron survival (Ellis et al., 2013); Syntaxin 3
(Stx3), a SNARE component gene; and Clta, a clathrin light chain
A gene, which show clear axon-specific usage of first, last, and
internal exons, respectively (Figures 6D, 6E, and S6A). Intrigu-
ingly, axon-specific isoforms of Acot7 and Stx3 encode proteins
with slightly different amino acids at the N and C termini, respec-
tively (see gene models in Figures 6D and 6E), suggesting that
alternative splicing may couple axon-specific protein isoforms
with a unique sequence tag in the UTR.
Unexpectedly, we detected a number of back splicing events
for three genes (Rhobtb3, Ubn2, and Ankrd12), which indicate
the potential presence of circRNAs in the axonal, but not in the
retinal, translatome, and we could detect these mRNAs by RT-
PCR of unamplified axonal translatome (Figure S6B). Although
previous studies suggested that the circRNAs are not translated
(Guo et al., 2014), our result raises the possibility that the ribo-
somes can associate with circRNAs in axons. However, further
studies are needed to address whether proteins are actually syn-
thesized from these circRNAs.
Cis-Regulatory Elements Couple Alternative Splicing
with Axonal Translation
The dominance of a single alternative exon in axons suggests
that axonal mRNA translation might be mechanistically linked
to alternative splicing. We focused on the axonally enriched
mRNAs with an alternative first or last exon because 50 and 30
UTRs generally contain localization signals (references in Jung
et al., 2012; Figures 6D and 6E). In order to investigate whether
the axon-specific exons are sufficient to promote axonal
mRNA transport and translation, we used a diffusion-limited,
membrane-targeted EGFP (myr-d2EGFP), which is a faithful re-
porter of local protein synthesis in dendrites (Aakalu et al., 2001)
and in axons (Andreassi et al., 2010; Cox et al., 2008). We fused
the axon-specific or axon-absent (retina-restricted) alternative
exon of each gene tomyr-d2EGFP so that a reporter mRNA con-
taining each motif would be generated in cells (Figures 7A and
7B). To test these reporters in RGCs, the same cell type from
which they were identified, we used Xenopus primary retinal
cultures (Campbell and Holt, 2001), which are amenable to
screening multiple motifs. We confirmed that alternative usages
of the 50 and 30 UTRs of Acot7 and Stx3, respectively, are
conserved between mouse and Xenopus (Xenbase and UCSC
genome browser). Fluorescence recovery after photobleaching
(FRAP) was monitored in the growth cones of cultured RGCs
at 1-min intervals for 10 min. Remarkably, the axon-specific
Figure 7. Cis-Regulatory Elements Link Alternative Splicing to
Axonal Translation
(A and B) Axon- and retina-specific Acot7 and Stx3 UTR isoforms fused with
myr-d2EGFP were expressed in cultured RGCs (Xenopus). Quantification of
fluorescence intensity after photobleaching (FRAP) revealed axon-specific
isoforms of Acot7 (A) and Stx3 (B) markedly increase axonal translation of theisoforms showed rapid and robust FRAP signals, whereas
the retina-specific isoforms did not (Figures 7A and 7B). These
results indicate that axon-specific exons of Acot7 and Stx3
are sufficient to promote axonal mRNA translation (Figures 7A
and 7B).
We next investigated whether axon-specific exons might
contain ‘‘generalizable’’ motifs responsible for axonal mRNA
translation. We searched for common sequence elements that
are enriched in axon-specific alternative exons (Figure 7C) and
in the 50 and 30 UTRs in constitutive exons (Figures S7A and
S7B) of axon-enriched mRNAs (Figure 3A). To understand the
potential function of identified sequence elements, we searched
for genes that contain these elements in the entire mouse
genome. Remarkably, the element-containing genes generally
encode regulators of axon and synapse function (Figures 7C
and S7C). Strikingly, five of six motifs identified from alternative
exons and five of twelve motifs in constitutive exons of axon-en-
richedmRNAs showed a significant FRAP signal at 10min, indic-
ative of increased axonal mRNA translation of a reporter mRNA
when incorporated in the 50 or 30 UTR as in Figure 7B (Figures 7C
and S7C). These results suggest the potential links between the
sequence elements and axonal mRNA translation and thus pro-
vide further insight into the mechanisms underlying the selective
and dynamic nature of the axonal mRNA translation.
DISCUSSION
Here, we developed a mouse model of axon-TRAP to isolate
mRNAs translated in the distal axon of RGCs in vivo and per-
formed a genome-wide survey of the axonal translatome at crit-
ical time points during the assembly of visual circuitry and in
adulthood. The axonal translatome is generally a subpopulation
of its somal counterpart but is enriched in genes with axon-spe-
cific roles. We found that broadly two classes of local transla-
tomes exist in the distal axon: one being constitutively translated
and the other being developmentally regulated. The former
generally encodes the regulators of protein and energy homeo-
stasis, and the latter encodes proteins required for stage-spe-
cific events, such as axon elongation, axon branching, synapsemyr-d2EGFP reporter construct compared to retina-specific UTR counter-
parts. Data at each 1 min time point represent the mean fraction of recovery
relative to pre- and post-bleach levels ± SEM (n = 9 and 10 for axon and eye-
specific 50 UTR of Acot7, respectively; n = 14 and 14 for axon and eye-specific
30 UTR of Stx3, respectively). ***p < 0.0001; two-way ANOVA. FRAP signal
recovery was abolished by 40 mM anisomycin (10 min post-photobleach:
Acot7 axon-isoform + anisomycin 0.064 ± 0.028; Stx3 axon-isoform + aniso-
mycin 0.085 ± 0.026). Representative images of RGC axonal growth cones
showing fluorescent recovery after photobleaching for each reporter construct
are shown (right). The scale bars represent 10 mm.
(C) GO enrichment analysis for entire genome containing axon-specific
sequence motifs associated with alternative exons (S: G or C) and their relative
efficiency in axonal mRNA translation using myr-d2EGFP reporter constructs.
Significance of FRAP recovery curves were compared to no UTR control
across 10 min (n R 10 for each construct). Statistical significance of FRAP
compared to the no-UTR control was tested across all time points (1–10 min)
using a two-way ANOVA (***p < 0.0001 compared to no-UTR control). For
representative purposes, the mean fluorescence recovery at 10 min post-
photobleaching is shown. Error bars represent SEM.
See also Figure S7.
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formation, and synaptic transmission. The adult axonal transla-
tome is unique, and its main role is likely to regulate synapse
function. Developmentally regulated translatomes were subdi-
vided according to the changes in translation between stages,
and those that showed a coordinate change were found to share
common upstream regulators, such as mTORC1, FMRP, and
APC, as well as novel sequence elements that possibly regulate
axonal mRNA translation. Additionally, we found that axonally
translated mRNAs were frequently specific splice variants that
carried axon-specific motifs. Together, our results show that
extensive local mRNA translation occurs in the developing and
mature mammalian CNS axons in vivo and provide strong evi-
dence that highly regulated axonal mRNA translation might be
at the heart of CNS development and the maintenance of synap-
tic function.
Previous studies using cultured neurons have revealed that
some mRNAs are stored in a translationally repressed state
(Buxbaum et al., 2014; Graber et al., 2013). Two independent
and complementary approaches have been developed to ask
which mRNAs are translated in the axon (Kim and Jung, 2015):
metabolic labeling of newly synthesized proteins and isolation
of ribosome-bound mRNAs. Proteomic approaches provide
the ultimate readout of gene expression, as they can identify
post-translationally modified protein products, but a critical lim-
itation of proteomics is that the probe-tagged amino acid or its
analogs label all cells, limiting its use to compartmentalized
axon culture. An alternative strategy to identify newly synthe-
sized proteins is to look at translated mRNAs (translatome),
because these are the obligate precursor to the de novo prote-
ome. A key advantage of this approach is that ribosomes can
be isolated from a specific cell type by expressing a genetically
encoded epitope-tagged ribosomal protein in just the cells of in-
terest (TRAP; Heiman et al., 2008). Isolated ribosome-mRNA
complexes either can be partially digested by RNase, and the
fragments protected by ribosome binding can be sequenced
(‘‘ribosome profiling’’; Ingolia et al., 2011), or the entire mRNA
can be separated from the ribosome and directly sequenced.
Only the latter method, which we use in this study, allows the dis-
covery of novel isoforms outside the protein-coding region.
We compared translatomes of RGC axons and retinal cell
bodies in the same animals. It should be noted that the retinal
translatome includes the translatome of the short axons and
dendrites of the intraretinal circuitry, as well as their cell bodies.
Therefore, the number ofmRNAs that are identified as selectively
translated in the axon in this study may be an underestimation.
Additionally, the expression of tagged ribosomes in non-RGC
retinal neurons can potentially introduce bias into the axon/
soma ratio. However, given the previous observations on retinal
cell populations (Young, 1985), the presence of non-RGC
mRNAs in the retinal sample cannot explain the axonal enrich-
ment of mRNAs above the threshold (FPKMaxon/FPKMretina >
100), which we used for the axon-soma comparison. The strong
enrichment of genes with axonal function in the axonal transla-
tome compared to the retinal translatome suggests that these
mRNAs were disproportionately represented in the axonal trans-
latome, indicating that axonal translation is mRNA specific.
In this study, we show that the RGC axonal translatome
changes in a developmental-stage-specific manner, in such a190 Cell 166, 181–192, June 30, 2016way that proteins playing a key role at specific periods are syn-
thesized when needed. This result is in agreement with a recent
study using the Drosophila visual system, which reported that
neuronal differentiation associated with maturation of presynap-
tic terminals is regulated by coordinate control of mRNA transla-
tion (Zhang et al., 2016), although the subcellular location of
mRNA translation was not addressed in that study. Whether sig-
nals that regulate mRNA-specific translation come from a cell-
intrinsic timer or cell-extrinsic cues remains to be investigated,
but our bioinformatic and experimental analyses suggest that
this involves stage-dependent activation of RNA-binding pro-
teins, including FMRP. Because FMRP is known to inhibit trans-
lation of proteins required for synapse formation and its loss of
function leads to over-branching of CNS axons (references in
Darnell and Richter, 2012), it is reasonable to assume that
FMRPmay be activated after CNS axons make appropriate syn-
apses to limit the number of synapses that a single axon makes.
In this sense, it is intriguing that defective translational machin-
ery, which is expected to affect all cells in the organism, leads
to enigmatically synapse-specific phenotypes, ranging from
defective synaptic transmission to impaired cognitive function
and memory (references in Buffington et al., 2014). Although
the subcellular location of this pathogenesis is unknown, it will
be interesting to test whether the axonal translatome of devel-
oping cortical neuronal axons in these mouse models of neuro-
developmental disorders is any different from normal mice.
The local mRNA translation in axons of mature neurons has
been a subject of long-standing debate (Piper and Holt, 2004).
Evidence indicates that ribosomes exist in mature CNS axons
(Koenig et al., 2000; Kun et al., 2007; Walker et al., 2012) and
that their number is dynamically regulated under normal and
pathological conditions (Verheijen et al., 2014). However, what
proteins are locally translated in the mature axons was
unknown. Our comparative analysis of mature and developing
retinal axonal translatomes suggests that local protein synthe-
sis regulates synaptic transmission and axon maintenance.
Because axonal translation has been implicated in axonal sur-
vival and degeneration (Jung et al., 2012), it will be important
to find out whether pathological axon degeneration is preceded
by defective axonal translation. The power of axon-TRAP is that
it can be extended to other neurons whose cell bodies and axons
are anatomically separated. One such example is cortical and
spinal motor neurons, whose axonal degeneration leads to hu-
man diseases, such as amyotrophic lateral sclerosis (ALS).
Recent evidence suggests that defective axonal mRNA transport
and translation may be an underlying cause of ALS pathology
(Alami et al., 2014; Murakami et al., 2015). Our new technical
approach and datasets should provide a valuable resource for
future studies.
EXPERIMENTAL PROCEDURES
Histological Analysis
For immunohistochemistry, tissue sections (12 mm) were visualized using an
anti-HA antibody (Abcam ab9110) and a secondary antibody conjugated to
Alexa 488 (Life Technologies). For immuno-gold EM, tissues were fixed in
4%paraformaldehyde in 0.1MHEPES (pH 7.4), and the HA-tagged ribosomes
were visualized by the same anti-HA antibody and immunoglobulin G (IgG)
conjugated with gold (10–15 nm). Mouse RGC axon culture and QIF were
performed as previously described (Zivraj et al., 2010) using the following
antibodies: anti-mTOR (phospho S2448) antibody (Abcam 109268), anti-
FMRP antibody (Abcam 17722), and anti-RPS6 (phospho S235 + S236) anti-
body (Abcam 12864).
Axon-TRAP
A homozygote RiboTag female mouse wasmated with a Pax6-alpha-Cre male
to produce Cre-positive and Cre-negative mice in a single litter. Three eyes or
six SCs were homogenized, and post-mitochondrial fractions were collected.
The mRNA-ribosome complexes were precipitated using the polyclonal HA
antibody and Dynabeads Protein G (Life Technologies 10004D). For the
in vitro ribosome run-off experiments, TRAP was performed after lysate was
incubated with rabbit reticulocyte lysate (Promega), harringtonine (Sigma),
and 4E1RCat (Sigma) at 37C for 30 min. Ribosome-bound mRNAs were
amplified by a method developed by Tang et al. (2009) with slight modification
and sequenced using Illumina HiSeq2000 or NextSeq500. All experiments
complied with protocols approved by the University of Cambridge and the
Yonsei University College of Medicine Institutional Animal Care and Use
Committees.
Data Analysis
The sequence reads were mapped using TopHat 2 version 2.0.12, and FPKM
values were estimated using Cufflinks. Read counts for each gene were deter-
mined using HTSeq version 0.6.1p1. For the identification of translatedmRNAs
in RGC axons, we applied differential gene expression analysis on read count
using NOISeq. De novo motif analysis was performed using HOMER version
3.0 with custom FASTA files.
A detailed description of all experimental procedures is provided in the Sup-
plemental Information.
ACCESSION NUMBERS
The accession number for the RNA-seq data reported in this paper is GEO:
GSE79352.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cell.2016.05.029.
AUTHOR CONTRIBUTIONS
H.J. and C.E.H. conceived and supervised the project. H.J. performed histo-
logical experiments. H.J. and T.S. performed biochemical and molecular bio-
logical experiments. T.S. performed bioinformatic analyses. J.J. performed
Cre specificity experiments, J.O. performed motif imaging and QIF, and
B.T.-B. and J.Q.L. performed FRAP and QIF. P.S.A. provided RiboTag
mice and the original TRAP protocol. H.J., T.S., and C.E.H. wrote the
manuscript.
ACKNOWLEDGMENTS
We apologize to authors of key papers, which we could not cite due to space
limitations. We thank W. Harris for many valuable discussions and critical
reading of the manuscript. We thank A. Riccio for myr-d2EGFP; J. Skepper
for EM; Gihoon Son for advice on IPA; M. Minett for advice onmouse genetics;
and K. Mooslehner, A. Dwivedy, and Jeeun Song for technical assistance. This
work was supported by Wellcome Trust Programme Grant (085314/Z/08/Z),
European Research Council Advanced Grant (322817) to C.E.H., Cambridge
Wellcome Trust PhD programme in Developmental Biology (to B.T.-B.), Gates
Cambridge Scholarship (to J.Q.L.), Basic Science Research Program (NRF-
2013R1A1A1009625 and NRF-2014K2A7A1036305), Biomedical Technology
Development Program (NRF-2013M3A9D5072551), Brain Research Program
(NRF-2015M3C7A1028396) funded through the NRF by the Korean govern-
ment (MSIP), Yonsei University Future-Leading Research Initiative of 2015(2015-22-0095), and a faculty research grant from Yonsei University College
of Medicine for 2013 (6-2013-0064-2-1) to H.J.
Received: November 26, 2015
Revised: March 9, 2016
Accepted: May 4, 2016
Published: June 16, 2016
REFERENCES
Aakalu, G., Smith, W.B., Nguyen, N., Jiang, C., and Schuman, E.M. (2001). Dy-
namic visualization of local protein synthesis in hippocampal neurons. Neuron
30, 489–502.
Alami, N.H., Smith, R.B., Carrasco, M.A., Williams, L.A., Winborn, C.S., Han,
S.S., Kiskinis, E., Winborn, B., Freibaum, B.D., Kanagaraj, A., et al. (2014).
Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing muta-
tions. Neuron 81, 536–543.
Andreassi, C., Zimmermann, C., Mitter, R., Fusco, S., De Vita, S., Saiardi, A.,
and Riccio, A. (2010). An NGF-responsive element targets myo-inositol mono-
phosphatase-1 mRNA to sympathetic neuron axons. Nat. Neurosci. 13,
291–301.
Bagni, C., and Greenough, W.T. (2005). From mRNP trafficking to spine dys-
morphogenesis: the roots of fragile X syndrome. Nat. Rev. Neurosci. 6,
376–387.
Baleriola, J., Walker, C.A., Jean, Y.Y., Crary, J.F., Troy, C.M., Nagy, P.L., and
Hengst, U. (2014). Axonally synthesized ATF4 transmits a neurodegenerative
signal across brain regions. Cell 158, 1159–1172.
Ben-Yaakov, K., Dagan, S.Y., Segal-Ruder, Y., Shalem, O., Vuppalanchi, D.,
Willis, D.E., Yudin, D., Rishal, I., Rother, F., Bader, M., et al. (2012). Axonal tran-
scription factors signal retrogradely in lesioned peripheral nerve. EMBO J. 31,
1350–1363.
Brunet, I., Weinl, C., Piper, M., Trembleau, A., Volovitch, M., Harris, W., Pro-
chiantz, A., and Holt, C. (2005). The transcription factor Engrailed-2 guides
retinal axons. Nature 438, 94–98.
Buffington, S.A., Huang, W., and Costa-Mattioli, M. (2014). Translational con-
trol in synaptic plasticity and cognitive dysfunction. Annu. Rev. Neurosci. 37,
17–38.
Buxbaum, A.R., Wu, B., and Singer, R.H. (2014). Single b-actin mRNA detec-
tion in neurons reveals a mechanism for regulating its translatability. Science
343, 419–422.
Campbell, D.S., and Holt, C.E. (2001). Chemotropic responses of retinal
growth cones mediated by rapid local protein synthesis and degradation.
Neuron 32, 1013–1026.
Campbell, D.S., and Holt, C.E. (2003). Apoptotic pathway andMAPKs differen-
tially regulate chemotropic responses of retinal growth cones. Neuron 37,
939–952.
Campbell, D.S., and Okamoto, H. (2013). Local caspase activation interacts
with Slit-Robo signaling to restrict axonal arborization. J. Cell Biol. 203,
657–672.
Copp, J., Manning, G., and Hunter, T. (2009). TORC-specific phosphorylation
of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for
intact mTOR signaling complex 2. Cancer Res. 69, 1821–1827.
Cosker, K.E., Fenstermacher, S.J., Pazyra-Murphy, M.F., Elliott, H.L., and Se-
gal, R.A. (2016). The RNA-binding protein SFPQ orchestrates an RNA regulon
to promote axon viability. Nat. Neurosci. 19, 690–696.
Cox, L.J., Hengst, U., Gurskaya, N.G., Lukyanov, K.A., and Jaffrey, S.R. (2008).
Intra-axonal translation and retrograde trafficking of CREB promotes neuronal
survival. Nat. Cell Biol. 10, 149–159.
Darnell, J.C., and Klann, E. (2013). The translation of translational control by
FMRP: therapeutic targets for FXS. Nat. Neurosci. 16, 1530–1536.
Darnell, J.C., and Richter, J.D. (2012). Cytoplasmic RNA-binding proteins and
the control of complex brain function. Cold Spring Harb. Perspect. Biol. 4,
a012344.Cell 166, 181–192, June 30, 2016 191
Darnell, J.C., Van Driesche, S.J., Zhang, C., Hung, K.Y., Mele, A., Fraser, C.E.,
Stone, E.F., Chen, C., Fak, J.J., Chi, S.W., et al. (2011). FMRP stalls ribosomal
translocation on mRNAs linked to synaptic function and autism. Cell 146,
247–261.
Ellis, J.M., Wong, G.W., and Wolfgang, M.J. (2013). Acyl coenzyme A thio-
esterase 7 regulates neuronal fatty acid metabolism to prevent neurotoxicity.
Mol. Cell. Biol. 33, 1869–1882.
Feldheim, D.A., and O’Leary, D.D. (2010). Visual map development: bidirec-
tional signaling, bifunctional guidance molecules, and competition. Cold
Spring Harb. Perspect. Biol. 2, a001768.
Gerdts, J., Brace, E.J., Sasaki, Y., DiAntonio, A., and Milbrandt, J. (2015).
SARM1 activation triggers axon degeneration locally via NAD+ destruction.
Science 348, 453–457.
Godement, P., Salau¨n, J., and Imbert, M. (1984). Prenatal and postnatal devel-
opment of retinogeniculate and retinocollicular projections in the mouse.
J. Comp. Neurol. 230, 552–575.
Graber, T.E., He´bert-Seropian, S., Khoutorsky, A., David, A., Yewdell, J.W.,
Lacaille, J.C., and Sossin, W.S. (2013). Reactivation of stalled polyribosomes
in synaptic plasticity. Proc. Natl. Acad. Sci. USA 110, 16205–16210.
Guo, J.U., Agarwal, V., Guo, H., and Bartel, D.P. (2014). Expanded identifica-
tion and characterization of mammalian circular RNAs. Genome Biol. 15, 409.
Heiman, M., Schaefer, A., Gong, S., Peterson, J.D., Day, M., Ramsey, K.E.,
Sua´rez-Farin˜as, M., Schwarz, C., Stephan, D.A., Surmeier, D.J., et al. (2008).
A translational profiling approach for the molecular characterization of CNS
cell types. Cell 135, 738–748.
Hillefors, M., Gioio, A.E., Mameza, M.G., and Kaplan, B.B. (2007). Axon
viability and mitochondrial function are dependent on local protein synthesis
in sympathetic neurons. Cell. Mol. Neurobiol. 27, 701–716.
Holt, C.E., and Schuman, E.M. (2013). The central dogma decentralized: new
perspectives on RNA function and local translation in neurons. Neuron 80,
648–657.
Ingolia, N.T., Lareau, L.F., and Weissman, J.S. (2011). Ribosome profiling of
mouse embryonic stem cells reveals the complexity and dynamics of mamma-
lian proteomes. Cell 147, 789–802.
Ji, S.J., and Jaffrey, S.R. (2012). Intra-axonal translation of SMAD1/5/8 medi-
ates retrograde regulation of trigeminal ganglia subtype specification. Neuron
74, 95–107.
Jung, H., Yoon, B.C., and Holt, C.E. (2012). Axonal mRNA localization and local
protein synthesis in nervous system assembly, maintenance and repair. Nat.
Rev. Neurosci. 13, 308–324.
Katz, Y., Wang, E.T., Airoldi, E.M., and Burge, C.B. (2010). Analysis and design
of RNA sequencing experiments for identifying isoform regulation. Nat.
Methods 7, 1009–1015.
Kim, E., and Jung, H. (2015). Local protein synthesis in neuronal axons: why
and how we study. BMB Rep. 48, 139–146.
Koenig, E., Martin, R., Titmus, M., and Sotelo-Silveira, J.R. (2000). Cryptic pe-
ripheral ribosomal domains distributed intermittently along mammalian
myelinated axons. J. Neurosci. 20, 8390–8400.
Kun, A., Otero, L., Sotelo-Silveira, J.R., and Sotelo, J.R. (2007). Ribosomal dis-
tributions in axons of mammalian myelinated fibers. J. Neurosci. Res. 85,
2087–2098.
Laplante, M., and Sabatini, D.M. (2012). mTOR signaling in growth control and
disease. Cell 149, 274–293.
Marquardt, T., Ashery-Padan, R., Andrejewski, N., Scardigli, R., Guillemot, F.,
and Gruss, P. (2001). Pax6 is required for the multipotent state of retinal pro-
genitor cells. Cell 105, 43–55.192 Cell 166, 181–192, June 30, 2016Martin, K.C., and Ephrussi, A. (2009). mRNA localization: gene expression in
the spatial dimension. Cell 136, 719–730.
Murakami, T., Qamar, S., Lin, J.Q., Schierle, G.S., Rees, E., Miyashita, A.,
Costa, A.R., Dodd, R.B., Chan, F.T., Michel, C.H., et al. (2015). ALS/FTD mu-
tation-induced phase transition of FUS liquid droplets and reversible hydrogels
into irreversible hydrogels impairs RNP granule function. Neuron 88, 678–690.
Pinheiro, P.S., and Mulle, C. (2008). Presynaptic glutamate receptors: physio-
logical functions and mechanisms of action. Nat. Rev. Neurosci. 9, 423–436.
Piper, M., and Holt, C. (2004). RNA translation in axons. Annu. Rev. Cell Dev.
Biol. 20, 505–523.
Preitner, N., Quan, J., Nowakowski, D.W., Hancock, M.L., Shi, J., Tcherkezian,
J., Young-Pearse, T.L., and Flanagan, J.G. (2014). APC is an RNA-binding pro-
tein, and its interactome provides a link to neural development and microtu-
bule assembly. Cell 158, 368–382.
Riccio, A., Pierchala, B.A., Ciarallo, C.L., and Ginty, D.D. (1997). An NGF-TrkA-
mediated retrograde signal to transcription factor CREB in sympathetic neu-
rons. Science 277, 1097–1100.
Sanz, E., Yang, L., Su, T., Morris, D.R., McKnight, G.S., and Amieux, P.S.
(2009). Cell-type-specific isolation of ribosome-associated mRNA from com-
plex tissues. Proc. Natl. Acad. Sci. USA 106, 13939–13944.
Sasaki, Y., Gross, C., Xing, L., Goshima, Y., and Bassell, G.J. (2014). Identifi-
cation of axon-enriched microRNAs localized to growth cones of cortical neu-
rons. Dev. Neurobiol. 74, 397–406.
Simon, D.J., Weimer, R.M., McLaughlin, T., Kallop, D., Stanger, K., Yang, J.,
O’Leary, D.D., Hannoush, R.N., and Tessier-Lavigne, M. (2012). A caspase
cascade regulating developmental axon degeneration. J. Neurosci. 32,
17540–17553.
Spillane, M., Ketschek, A., Merianda, T.T., Twiss, J.L., and Gallo, G. (2013).
Mitochondria coordinate sites of axon branching through localized intra-
axonal protein synthesis. Cell Rep. 5, 1564–1575.
Tang, F., Barbacioru, C., Wang, Y., Nordman, E., Lee, C., Xu, N., Wang, X.,
Bodeau, J., Tuch, B.B., Siddiqui, A., et al. (2009). mRNA-seq whole-transcrip-
tome analysis of a single cell. Nat. Methods 6, 377–382.
Tarazona, S., Garcı´a-Alcalde, F., Dopazo, J., Ferrer, A., and Conesa, A. (2011).
Differential expression in RNA-seq: a matter of depth. Genome Res. 21, 2213–
2223.
Verheijen, M.H., Peviani, M., Hendricusdottir, R., Bell, E.M., Lammens, M.,
Smit, A.B., Bendotti, C., and vanMinnen, J. (2014). Increased axonal ribosome
numbers is an early event in the pathogenesis of amyotrophic lateral sclerosis.
PLoS ONE 9, e87255.
Walker, B.A., Hengst, U., Kim, H.J., Jeon, N.L., Schmidt, E.F., Heintz, N., Mil-
ner, T.A., and Jaffrey, S.R. (2012). Reprogramming axonal behavior by axon-
specific viral transduction. Gene Ther. 19, 947–955.
Yoon, B.C., Jung, H., Dwivedy, A., O’Hare, C.M., Zivraj, K.H., and Holt, C.E.
(2012). Local translation of extranuclear lamin B promotes axon maintenance.
Cell 148, 752–764.
Young, R.W. (1985). Cell differentiation in the retina of the mouse. Anat. Rec.
212, 199–205.
Zhang, K.X., Tan, L., Pellegrini, M., Zipursky, S.L., and McEwen, J.M. (2016).
Rapid changes in the translatome during the conversion of growth cones to
synaptic terminals. Cell Rep. 14, 1258–1271.
Zivraj, K.H., Tung, Y.C., Piper, M., Gumy, L., Fawcett, J.W., Yeo, G.S., and
Holt, C.E. (2010). Subcellular profiling reveals distinct and developmentally
regulated repertoire of growth cone mRNAs. J. Neurosci. 30, 15464–15478.
